Certainty assessment | № of patients | Effect | Certainty | Importance | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
№ of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | [mifepristone and misoprostol] | [misoprostol] | Relative (95% CI) | Absolute (95% CI) | ||
Induction delivery interval | ||||||||||||
10 | randomised trials | seriousa | not seriousb | not serious | not serious | publication bias strongly suspectedc | 356 | 354 | - | MD 7.86 lower (9.98 lower to 5.73 lower) | ⨁⨁◯◯ Lowa,b,c | CRITICAL |
Number of misoprostol doses | ||||||||||||
9 | randomised trials | seriousa | not seriousb | not serious | not serious | none | 315 | 316 | - | MD 1.38 lower (1.82 lower to 0.94 lower) | ⨁⨁⨁◯ Moderatea,b | CRITICAL |
Total dose of misoprostol | ||||||||||||
4 | randomised trials | seriousa | not seriousb | not serious | seriousd | none | 165 | 172 | - | MD 60.51 lower (106.98 lower to 14.04 lower) | ⨁⨁◯◯ Lowa,b,d | CRITICAL |